Thinking of joining a study?

Register your interest

NCT03045289 | COMPLETED | Metastatic Breast Cancer


A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer
Sponsor:

University of Rochester

Information provided by (Responsible Party):

Thomas M Campbell

Brief Summary:

This research will examine the feasibility of conducting a strict whole-food, plant-based dietary intervention in women with stable metastatic breast cancer currently undergoing conventional treatments. In addition, this research will provide preliminary data on dietary intakes and the effect of plant-based nutrition on numerous outcomes reflecting cancer prognosis and overall health using advanced imaging, various blood biomarkers linked to cancer progression, and numerous symptom questionnaires.

Condition or disease

Metastatic Breast Cancer

Breast Cancer Stage IV

Intervention/treatment

Plant-Based Diet

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 32 participants
Masking : SINGLE
Primary Purpose : TREATMENT
Official Title : Whole-Food, Plant-Based Nutrition Among Women With Metastatic Breast Cancer: A Pilot Study of Recruitment, Retention, and Preliminary Changes in Biomarkers and Symptoms.
Actual Study Start Date : 2018-07-05
Estimated Primary Completion Date : 2022-07-01
Estimated Study Completion Date : 2022-07-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Women with a confirmed diagnosis of metastatic breast cancer with a stable treatment regimen, demonstrated by no changes in primary cancer therapy 6 weeks prior to consent and no anticipated changes in primary cancer therapy in the 4 weeks following consent.
  • * Systemic therapy may consist of any conventional treatment including anti-hormonal, cytotoxic, targeted monoclonal antibody or small molecule kinase inhibitors or any combination of the above. Women who have previously declined conventional cancer therapy are also eligible provided they meet all other eligibility criteria.
  • * Expected to survive for at least 6 months.
  • * Eligibility classification for enrollment into the study - T: any; N: any; M:1.
  • * Any ER/PR/HER2 status is eligible.
  • * Age \> 18 years.
  • * Must be willing to adopt a strict, whole-foods, plant-based diet.
  • * Participant must be willing and able to comply with the protocol for the duration of the study including scheduled testing and weekly office visits.
  • * Able to speak and read English fluently.
Exclusion Criteria
  • * Inability to tolerate a normal diet.
  • * Current use of insulin or sulfonylureas.
  • * Active malabsorption syndrome at time of consent (ie. Crohn's disease, major bowel resection leading to permanent malabsorption).
  • * Current eating disorder.
  • * Uncontrolled diarrhea.
  • * Plant-based food allergies or intolerances.
  • * Recent consumption (in the past 6 months) of a vegan diet.
  • * GFR \< 30 on 2 or more lab tests in the past 90 days.
  • * Serum potassium \> 5.3 on 2 or more lab tests in the past 90 days.
  • * Major surgery within 2 months of starting study program.
  • * Psychiatric disorder that prohibits giving informed consent.
  • * Current smoking.
  • * Current high risk alcohol use (\> 7 drinks per week).
  • * Current illicit substance use.
  • * Current warfarin use.

A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer

Location Details

NCT03045289


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, New York

University of Rochester

Rochester, New York, United States, 14642

Loading...